The Application Notebook
Polar lipids and other metabolites extracted from plasma from lean, diabetic, and obese Zucker rats were analyzed by flow injection using high resolution time of flight mass spectrometry. Metabolites were confidently identified and differences in the metabolite profiles determined.
Polar lipids and other metabolites extracted from plasma from lean, diabetic, and obese Zucker rats were analyzed by flow injection using high resolution time of flight mass spectrometry. Metabolites were confidently identified and differences in the metabolite profiles determined.
The need for high-throughput analysis of biological samples is of growing importance owing to its clinical utility and the ability to leverage new developments in technology. This is particularly true in metabolomics where screening to evaluate significant differences in key metabolites and metabolite families can be selectively observed using new tools. One such tool is high performance time of flight mass spectrometry. The mass accuracy and resolving power now offered allows for confident evaluation of metabolites with little sample preparation.
Rat plasma (Zucker; Bioreclamation) was precipitated with 80% cold methanol and the supernatant analyzed directly. Polar lipids in the extracts were analyzed by injection into a stream of acetonitrile/water with formic acid.
Table I: Representative analytes detected in samples with mass error and change (Delta) in plasma from obese vs. lean rats
Mass Spectrometer – Citius™ LC-HRT (LECO Corporation, Saint Joseph, MI)
Mass Range – 240–940
Acquisition Conditions – 1 spectra/s; R =100,000; positive ion mode
Solvent delivery Conditions – 60 µL /min (acetonitrile/water/0.1% formic acid)
Injection Volume – 2 µL
Acquisition time – 2 min
The analyses provided a rich spectrum which can be background subtracted to yield useful information on the lipid content of the simple plasma extract. This is shown in Figure 1 for data acquired at 100,000 resolving power. The resolving power allows for separation of the M+H+2 isotope and M+H of unsaturated forms as shown for PCs containing 34 carbons. This requires a resolving power in excess of 80,000.
Figure 1: Mass spectrum at R > 100,000 from plasma extract â (top) full acquisition; (bottom) M+2 isotope of PC34:2 and the M of PC34:1 resolved.
The direct analysis of lipids using high performance time of flight provides a quick and efficient tool to screen differences in lipids in complex extracts. The analysis time of 2 min provides for a rapid evaluation with the high resolving power allowing for selective analysis.
LECO Corporation
3000 Lakeview Avenue, St. Joseph, MI 49085
tel. (269) 985-5496, fax (269) 982-8977
Website: www.leco.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.